Efficacy and Safety of Saxagliptin in Combination With Insulin in Elderly Patients With Type 2 Diabetes

被引：0
|
作者：
Charbonnel, Bernard
Barnett, Anthony H.
Monyak, John
Minervini, Gianmaria
Iqbal, Nayyar
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1048-P
引用
收藏
页码：A269 / A269
页数：1
相关论文
共 50 条
  • [21] Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
    Jain, Rajeev
    ADVANCES IN THERAPY, 2015, 32 (11) : 1065 - 1084
  • [22] Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
    Rajeev Jain
    Advances in Therapy, 2015, 32 : 1065 - 1084
  • [23] Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis
    Men, Peng
    Li, Xiao-tong
    Tang, Hui-lin
    Zhai, Suo-di
    PLOS ONE, 2018, 13 (05):
  • [24] Efficacy and safety of saxagliptin (SAXA) in patients with type 2 diabetes stratified by cardiovascular risk factors
    Allen, E.
    Slater, J.
    Bryzinski, B.
    Donovan, M.
    Cook, W.
    DIABETOLOGIA, 2012, 55 : S346 - S347
  • [25] Rosiglitazone: safety and efficacy in combination with insulin in poorly controlled type 2 diabetes mellitus patients treated with insulin alone
    Garg, Ranjna
    Gopal, Jayanthi
    Jones, Geraint Rhys
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (01) : 1 - 6
  • [26] Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus - a phase 4 study in India
    Wangnoo, S. K.
    Bhadada, Sanjay Kumar
    Farishta, Faraz
    Naidu, Girithara Gopalakrishnan Jayaram
    Pattnaik, Indira
    Manohar, K. N.
    Singh, K. P.
    Gupta, Sandeep Kumar
    Bharath, H. S.
    Ghosh, Sujoy
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [27] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [28] Safety and Efficacy of Linagliptin and Basal Insulin Combination Therapy in Elderly Patients (age ≥70 years) with Type 2 Diabetes (T2D)
    Woerle, H. J.
    Neubacher, D.
    Patel, S.
    von Eynatten, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S31 - S32
  • [29] Safety and efficacy of linagliptin plus basal insulin combination therapy in a vulnerable population of elderly patients (age ≥70 years) with type 2 diabetes
    Woerle, H. -J.
    Neubacher, D.
    Patel, S.
    von Eynatten, M.
    DIABETOLOGIA, 2012, 55 : S350 - S350
  • [30] EFFICACY AND SAFETY OF SAXAGLIPTIN, DIPEPTIDYL PEPTIDASE-4 INHIBITOR, IN HEMODIALYSIS PATIENTS WITH TYPE 2 DIABETES
    Abe, M.
    Otsuki, T.
    Maruyama, N.
    Oikawa, O.
    Okada, K.
    NEPHROLOGY, 2016, 21 : 65 - 65
12345